BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.30M | 6.65M | 10.91M | 5.34M | 4.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.30M | 6.65M | 10.91M | 5.34M | 4.39M |
| Cost of Revenue | 2.52M | 5.51M | 7.23M | 4.12M | 3.07M |
| Gross Profit | 773.30K | 1.14M | 3.68M | 1.21M | 1.32M |
| SG&A Expenses | 712.70K | 925.30K | 1.46M | 826.30K | 892.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -29.50K | -3.10K | -- | -- |
| Total Operating Expenses | 3.25M | 6.41M | 8.69M | 4.96M | 3.97M |
| Operating Income | 50.90K | 240.30K | 2.22M | 375.00K | 416.00K |
| Income Before Tax | 35.20K | 171.20K | 2.19M | 337.90K | 344.90K |
| Income Tax Expenses | 9.30K | 49.20K | 579.50K | 89.50K | 89.70K |
| Earnings from Continuing Operations | 25.90K | 122.00K | 1.61M | 248.30K | 255.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.90K | 122.00K | 1.61M | 248.30K | 255.20K |
| EBIT | 50.90K | 240.30K | 2.22M | 375.00K | 416.00K |
| EBITDA | 144.60K | 290.40K | 2.36M | 429.60K | 470.70K |
| EPS Basic | 0.00 | 0.01 | 0.10 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.09 | 0.01 | 0.01 |
| EPS Diluted | 0.00 | -0.02 | 0.09 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.07 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 18.58M | 15.66M | 15.80M | 15.70M | 15.64M |
| Average Diluted Shares Outstanding | 18.58M | 15.66M | 18.64M | 18.52M | 18.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |